Your browser doesn't support javascript.
loading
Anticancer perspectives of monocarbonyl analogs of curcumin: A decade (2014-2024) review.
Nagargoje, Amol A; Deshmukh, Tejshri R; Shaikh, Mubarak H; Khedkar, Vijay M; Shingate, Bapurao B.
Afiliação
  • Nagargoje AA; Department of Chemistry, Dr. Babasaheb Ambedkar Marathwada University, Chhatrapati Sambhajinagar (Aurangabad), Maharashtra, India.
  • Deshmukh TR; Department of Chemistry, Khopoli Municipal Council College, Khopoli, Maharashtra, India.
  • Shaikh MH; Department of Chemistry, Dr. Babasaheb Ambedkar Marathwada University, Chhatrapati Sambhajinagar (Aurangabad), Maharashtra, India.
  • Khedkar VM; Department of Chemistry, Dr. Babasaheb Ambedkar Marathwada University, Chhatrapati Sambhajinagar (Aurangabad), Maharashtra, India.
  • Shingate BB; Department of Chemistry, Radhabai Kale Mahila Mahavidyalaya, Ahmednagar, Maharashtra, India.
Arch Pharm (Weinheim) ; 357(9): e2400197, 2024 Sep.
Article em En | MEDLINE | ID: mdl-38895952
ABSTRACT
Monocarbonyl analogs of curcumin (MACs) represent structurally modified versions of curcumin. The existing literature indicates that MACs exhibit enhanced anticancer properties compared with curcumin. Numerous research articles in recent years have emphasized the significance of MACs as effective anticancer agents. This review focuses on the latest advances in the anticancer potential of MACs, from 2014 to 2024, including discussions on their mechanism of action, structure-activity relationship (SAR), and in silico molecular docking studies.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Curcumina / Simulação de Acoplamento Molecular / Antineoplásicos Limite: Animals / Humans Idioma: En Revista: Arch Pharm (Weinheim) Ano de publicação: 2024 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Curcumina / Simulação de Acoplamento Molecular / Antineoplásicos Limite: Animals / Humans Idioma: En Revista: Arch Pharm (Weinheim) Ano de publicação: 2024 Tipo de documento: Article